Skip to main content

Table 4 Cost per case detected on SS and incremental cost-effectiveness ratio (ICER) for additional case detected on chest-x-ray

From: Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria

Test positive

Group

TB+ cases

% NTM

CER

ICER

     

With Oc

Without Oc

Sputum smear

All

169

3.6

$52.84

  

Sputum smear

HIV+

36

5.6

$57.06

  

Sputum smear

HIV-

133

3.0

$51.70

  

Chest-x-ray

SS-

82

29.3

 

$23.42

$22.68

Chest-x-ray

SS-HIV+

29

31.0

 

$15.77

$15.25

Chest-x-ray

SS-HIV-

53

28.3

 

$27.67

$25.49

  1. SS- Sputum smear negative, TB+ Tuberculosis positive, NTM Non tuberculous mycobacteria, HIV+ Human immune deficiency virus positive, CER Cost effectiveness ratio, Oc Opportunity cost.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us